Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Epigenetics|January 15, 2021
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survivalM Cabezón, R Malinverni, J Bargay, et al.Sangre|June 1, 1996
[Organizational models for the hematology areas of the district hospitals of Catalonia]R Salinas, A Asensio, E Tuset, et al.Leukemia|October 7, 2006
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosisN C Gutiérrez, M V Castellanos, M L Martín, et al.Leukemia|June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapyD Martínez-Cuadrón, P Montesinos, E Vellenga, et al.Blood Cancer Journal|October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.Bone Marrow Transplantation|October 29, 2021
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selectionR Parody, I Sánchez-Ortega, A Mussetti, et al.Leukemia|August 15, 2017
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targetsK Karube, A Enjuanes, I Dlouhy, et al.Pageof 3